RGS10 and ovarian carcinoma: Our results suggest that HDAC1 and DNMT1 contribute to the suppression of RGS10 during acquired chemoresistance and support growing evidence that inhibition of HDAC1/DNMT1 represent novel therapeutic approaches to overcoming ovarian cancer chemoresistance.